CompletedNot Applicable

Endoscopic Injection of Dextranomer/Hyaluronic Acid Versus Ureteral Reimplantation In Treatment of Vesicoureteral Reflux

60 participantsStarted 2015-06-04

Plain-language summary

In this study, the investigators aim to compare the outcomes of Dextranomer/hyaluronic acid (Dexell®) and extravesical reimplantation (Lich- Gregoir) procedures for primary vesicoureteral reflux (VUR) grades III and IV in children.

Who can participate

Age range1 Year – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Children over one year with primary Vesico-Ureteral reflux grade III and IV. Exclusion Criteria: * Secondary Vesico-Ureteral reflux. * Active urinary tract infection * Untreated voiding dysfunction.

What they're measuring

surgical success

Timeframe: 2 years

Trial details

NCT IDNCT04798443

SponsorElsayed Salih

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-05

View on ClinicalTrials.gov More Vesico-Ureteral Reflux trials